Claritev (CTEV) Stock Forecast, Price Target & Predictions
CTEV Stock Forecast
Claritev (CTEV) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $52.00, with a high of $73.00 and a low of $40.00. This represents a 107.75% increase from the last price of $25.03.
CTEV Stock Rating
Claritev stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
CTEV Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Claritev | 107.75% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Healthcare Information Services Stocks | 15.95% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 4 | 9 |
| Avg Price Target | - | $48.25 | $42.56 |
| Last Closing Price | $25.03 | $25.03 | $25.03 |
| Upside/Downside | - | 92.77% | 70.04% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Oct, 26 | 2 | 2 | 1 | - | - | 5 |
| Sep, 26 | 2 | 3 | 1 | - | - | 6 |
| Aug, 26 | 2 | 3 | 1 | - | - | 6 |
| Jul, 26 | 2 | 3 | 1 | - | - | 6 |
| Jun, 26 | 2 | 3 | 1 | - | - | 6 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Glen Santangelo | Barclays | $40.00 | $34.57 | 15.71% | 59.81% |
| Aug 12, 2026 | Jessica Tassan | Piper Sandler | $73.00 | $35.36 | 106.45% | 191.65% |
| Aug 10, 2026 | Canaccord Genuity | $43.00 | $32.59 | 31.94% | 71.79% | |
| Jul 21, 2026 | Canaccord Genuity | $37.00 | $30.12 | 22.84% | 47.82% | |
| Jun 03, 2026 | Piper Sandler | $61.00 | $25.00 | 144.00% | 143.71% | |
| Apr 24, 2026 | Barclays | $28.00 | $20.30 | 37.93% | 11.87% | |
| Feb 24, 2026 | Stan Berenshteyn | Wells Fargo | $30.00 | $23.23 | 29.14% | 19.86% |
| Feb 24, 2026 | Guggenheim | $38.00 | $23.23 | 63.58% | 51.82% | |
| Jan 08, 2026 | Stan Berenshteyn | Wells Fargo | $33.00 | $31.21 | 5.74% | 31.84% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 20, 2026 | Barclays | Overweight | Overweight | hold |
| Aug 12, 2026 | Piper Sandler | Overweight | Overweight | hold |
| Aug 10, 2026 | Citigroup | Buy | Buy | hold |
| May 13, 2026 | Citigroup | Buy | Buy | hold |
| Apr 24, 2026 | Barclays | Overweight | initialise | |
| Feb 24, 2026 | Guggenheim | Buy | Buy | hold |
| Oct 21, 2025 | Citigroup | Buy | upgrade | |
| Aug 15, 2025 | Piper Sandler | Overweight | Overweight | hold |
| May 29, 2025 | Piper Sandler | Overweight | upgrade |
Financial Forecast
EPS Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | $-5.69 | $-101.92 | $-17.30 | - | - |
| Avg Forecast | $-5.85 | $-80.71 | $-13.55 | $-10.42 | $-11.70 |
| High Forecast | $-5.80 | $-80.02 | $-13.44 | $-10.33 | $-11.60 |
| Low Forecast | $-5.90 | $-81.41 | $-13.67 | $-10.51 | $-11.80 |
| Surprise % | -2.74% | 26.28% | 27.68% | - | - |
Revenue Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | $961.52M | $930.62M | $965.41M | - | - |
| Avg Forecast | $964.42M | $935.49M | $922.51M | $960.61M | $1.01B |
| High Forecast | $970.80M | $939.52M | $926.08M | $969.50M | $1.02B |
| Low Forecast | $958.05M | $931.47M | $918.95M | $951.72M | $1.01B |
| Surprise % | -0.30% | -0.52% | 4.65% | - | - |
Net Income Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | $-91.70M | $-1.65B | $-284.28M | - | - |
| Avg Forecast | $-94.54M | $-1.30B | $-218.83M | $-167.75M | $-190.46M |
| High Forecast | $-93.72M | $-1.29B | $-216.95M | $-166.86M | $-187.37M |
| Low Forecast | $-95.35M | $-1.31B | $-220.71M | $-169.75M | $-190.61M |
| Surprise % | -3.00% | 26.28% | 29.91% | - | - |